• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 204-218 of 300 results

1037 Exhibit: Sukhatme

Document IPR2022-00855, No. 1037 Exhibit - Sukhatme (P.T.A.B. Apr. 12, 2022)

cite Cite Document
Analyze

1047 Exhibit: Davila

Document IPR2022-00855, No. 1047 Exhibit - Davila (P.T.A.B. Apr. 12, 2022)

cite Cite Document
Analyze

1002 Exhibit: Junghans Decl

Document IPR2022-00855, No. 1002 Exhibit - Junghans Decl (P.T.A.B. Apr. 12, 2022)

cite Cite Document
Analyze

1045 Exhibit: Kochenderfer 2010

Document IPR2022-00855, No. 1045 Exhibit - Kochenderfer 2010 (P.T.A.B. Apr. 12, 2022)

cite Cite Document
Analyze

2018 Exhibit: David L Porter et al, Randomized, Phase II Dose Optimization Study O...

Document IPR2022-00855, No. 2018 Exhibit - David L Porter et al, Randomized, Phase II Dose Optimization Study Of Chimeric Antigen Receptor Modified T Cells Directed Against CD 19 CTL019 In Patients...

cite Cite Document
Analyze

3003 Exhibit: Ex 3003

Document IPR2022-00855, No. 3003 Exhibit - Ex 3003 (P.T.A.B. May. 22, 2023)

cite Cite Document
Analyze

2013 Exhibit: Renier Brentjens et al, Treatment of chronic lymphocytic leukemia wit...

Document IPR2022-00855, No. 2013 Exhibit - Renier Brentjens et al, Treatment of chronic lymphocytic leukemia with genetically targeted autologous T cells case report of an unforeseen adverse event in a...

cite Cite Document
Analyze

2009 Exhibit: FOOD AND DRUG ADMIN, PRIORITY REVIEW Jan 4, 2018, httpswww...

Document IPR2022-00855, No. 2009 Exhibit - FOOD AND DRUG ADMIN, PRIORITY REVIEW Jan 4, 2018, httpswwwfdagovpatientsfast track breakthrough therapy accelerated approval priority reviewprior...

cite Cite Document
Analyze

2001 Exhibit: Jason Fagone, Has Carl June Found a Key to Fighting Cancer, PHILA...

Document IPR2022-00855, No. 2001 Exhibit - Jason Fagone, Has Carl June Found a Key to Fighting Cancer, PHILA MAG Aug 1, 2013 (P.T.A.B. Jul. 19, 2022)

cite Cite Document
Analyze

2019 Exhibit: Stephan A Grupp et al, T Cells Engineered With A Chimeric Antigen R...

Document IPR2022-00855, No. 2019 Exhibit - Stephan A Grupp et al, T Cells Engineered With A Chimeric Antigen Receptor CAR Targeting CD 19 CTL0l 9 Produce Significant In Vivo Proliferation, Complete...

cite Cite Document
Analyze

2028 Exhibit: World Intell Prop Org Patent Application No WO 02077029 A2

Document IPR2022-00855, No. 2028 Exhibit - World Intell Prop Org Patent Application No WO 02077029 A2 (P.T.A.B. Jul. 19, 2022)

cite Cite Document
Analyze

2008 Exhibit: FOOD AND DRUG ADMIN, BREAKTHROUGH THERAPY Jan 4, 2018...

Document IPR2022-00855, No. 2008 Exhibit - FOOD AND DRUG ADMIN, BREAKTHROUGH THERAPY Jan 4, 2018, httpswwwfdagovpatientsfast track breakthrough therapy accelerated approval priority re...

cite Cite Document
Analyze

2081 Exhibit: EX 2081

Document IPR2022-00855, No. 2081 Exhibit - EX 2081 (P.T.A.B. Feb. 13, 2023)

cite Cite Document
Analyze

2057 Exhibit: EX 2057

Document IPR2022-00855, No. 2057 Exhibit - EX 2057 (P.T.A.B. Feb. 13, 2023)

cite Cite Document
Analyze

2061 Exhibit: EX 2061

Document IPR2022-00855, No. 2061 Exhibit - EX 2061 (P.T.A.B. Feb. 13, 2023)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 14 15 16 17 18 ... >>